FDA recently awarded new chemical entity (NCE) exclusivity to Austedo™ (deutetrabenazine). The Austedo approval is notable for two reasons: One, it is the first deuterated drug (i.e., a drug ...
A chemical name is given when a new chemical entity (NCE) is developed. The chemical name is a scientific name based on the compound's chemical structure (e.g., 6-thioguanine) and is almost never ...
Dr. Madeleine King of the University of Nottingham, commented: "These findings appear extremely promising for the aminoindane new chemical entities. AW21003 showed positive effects on social transfer ...
XG005 is a non-opioid, new chemical entity with dual mode of action in targeting both nociceptive and neuropathic pain signals. The placebo, 750 mg or 1250 mg of XG005, was administered orally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback